Search research articles
Contact Us
Filters
Showing results (201-210 of 261) with videos related to
Page
of 27
Sort By:
Annals of Hepato-Biliary-Pancreatic Surgery
|
January 27, 2026
Simultaneous resection of pancreatic cancer and liver metastases following total neoadjuvant therapy: A case series and analysis of the National Cancer Database
McKenzie L Schaefer, Patrick L Quinn, Alexander H Shannon, et al.
Pancreas
|
July 20, 2022
Incidence and Risk Factors for New-Onset Diabetes Mellitus After Surgical Resection of Pancreatic Cystic Lesions: A MarketScan Study
Stephen A Firkins, Phil A Hart, Kyle Porter, et al.
Clinical Colorectal Cancer
|
February 16, 2024
Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review
Eric D Miller, Brett G Klamer, Jordan M Cloyd, et al.
Surgery
|
March 6, 2021
Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases
Diamantis I Tsilimigras, Kota Sahara, J Madison Hyer, et al.
Frontiers in Oncology
|
April 22, 2025
Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights
Ashish Manne, Yonghua Bao, Ankur Sheel, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 14, 2025
Hospital admission during neoadjuvant therapy for pancreatic ductal adenocarcinoma: prevalence, predictors, and prognosis
Patrick W Underwood, Thomas Leuschner, Amanda K Walsh, et al.
Pancreas
|
March 6, 2020
Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
Malcolm H Squires, Patrick J Worth, Bhavana Konda, et al.
Annals of Surgical Oncology
|
April 8, 2018
Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases
Jordan M Cloyd, Kiyohiko Omichi, Takashi Mizuno, et al.
The Journal of Surgical Research
|
May 7, 2022
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?
Eliza W Beal, J C Chen, Alex Kim, et al.
Frontiers in Oncology
|
January 24, 2025
Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Samantha M Ruff, Gyulnara Kasumova, Manoj Palavalli, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 261) with videos related to
Sort By:
Page
of 27
Annals of Hepato-Biliary-Pancreatic Surgery
|
January 27, 2026
Simultaneous resection of pancreatic cancer and liver metastases following total neoadjuvant therapy: A case series and analysis of the National Cancer Database
McKenzie L Schaefer, Patrick L Quinn, Alexander H Shannon, et al.
Pancreas
|
July 20, 2022
Incidence and Risk Factors for New-Onset Diabetes Mellitus After Surgical Resection of Pancreatic Cystic Lesions: A MarketScan Study
Stephen A Firkins, Phil A Hart, Kyle Porter, et al.
Clinical Colorectal Cancer
|
February 16, 2024
Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review
Eric D Miller, Brett G Klamer, Jordan M Cloyd, et al.
Surgery
|
March 6, 2021
Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases
Diamantis I Tsilimigras, Kota Sahara, J Madison Hyer, et al.
Frontiers in Oncology
|
April 22, 2025
Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights
Ashish Manne, Yonghua Bao, Ankur Sheel, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 14, 2025
Hospital admission during neoadjuvant therapy for pancreatic ductal adenocarcinoma: prevalence, predictors, and prognosis
Patrick W Underwood, Thomas Leuschner, Amanda K Walsh, et al.
Pancreas
|
March 6, 2020
Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
Malcolm H Squires, Patrick J Worth, Bhavana Konda, et al.
Annals of Surgical Oncology
|
April 8, 2018
Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases
Jordan M Cloyd, Kiyohiko Omichi, Takashi Mizuno, et al.
The Journal of Surgical Research
|
May 7, 2022
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?
Eliza W Beal, J C Chen, Alex Kim, et al.
Frontiers in Oncology
|
January 24, 2025
Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Samantha M Ruff, Gyulnara Kasumova, Manoj Palavalli, et al.
Page
of 27